Vinay Prasad, MD MPH

Plenary Session

Science EN ↓ 405 avsnitt

A podcast on medicine, oncology, & health policy. Host: Vinay Prasad, MD MPH from University of California, San Francisco. Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com.

Glöm inte att besöka poddens webbplats och stötta skaparen: soundcloud.com

Skapare

Vinay Prasad, MD MPH

Kategori

Science

Poddens webbplats

soundcloud.com

Senaste avsnittet

17 okt 2026

Var kan du lyssna?

Poddar i appen Replaio Radio Kommer snart

Poddar kommer snart till appen. Installera nu och bli först med att uppleva ett helt nytt sätt att lyssna på poddar

Installera gratis Android nästan 10 mn nedladdningar · betyg 4,8 iOS snart

Avsnitt

1.05 Cost and Efficacy of Cancer Drugs, ECHELON-1, Dr. Derrick Tao, and EBM with Dr. Martha Gerrity 05.09.2018 1:00:56

In this episode we cover the cost and efficacy of cancer drugs; review ECHELON-1; interview Dr. Derrick Tao of OHSU about his recent Lancet Oncology paper on poor control arms; and discuss evidence-based medicine with EBM expert and internist at OHSU, Dr. Martha Gerrity.

1.04: Nutritional Epi, Lenvatinib, Nivo and Ipi for Melanoma, and Dr. Avi O'Glasser 30.08.2018 56:53

This week's episode is on nutritional epidemiology by JPA Ioannidis; lenvatinib for hepatocellular carcinoma; nivolumab and ipilimumab for melanoma; and #medtwitter with Dr. Avi O Glasser from OHSU.

1.03: RWE, Right to Try, Talazoparib, Nivolumab, and Dr. Andrae Vandross 21.08.2018 1:06:02

We're moving to our new format. We begin with a monologue of the most noteworthy articles in this week's news. We'll be talking about real-world evidence, Right to Try, talazoparib, and the FDA approval for nivolumab in small-cell lung cancer. In the second half of the show, we'll interview Dr. Andrae Vandross, a community oncologist at UCLA Medical Center.

1.02: HemOnc Fellowship and Hype in Cancer Medicine with Dr. Jeremy Cetnar 16.08.2018 35:16

In episode 2, we discuss the fellowship program and then take a deep dive into hype surrounding cancer drugs. Our guest is Jeremy Cetnar, MD from Oregon Health & Science University.

1.01: Introduction and Dr. Adam Obley 14.08.2018 47:25

Join us for an introduction to who we are and what our podcast is about, then stick around for a hard-hitting discussion of evidence-based medicine, randomized controlled trials, sham controls, and broad next-generation sequencing in cancer. Our guest is Adam Obley, an Assistant Professor of Medicine at Oregon Health & Science University.